Intra-Cellular Therapies Stock Predictions

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

ITCI
Intra-Cellular Therapies

Last Price:

77.06

Seasonality Move:

-4.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 52.2% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $76.97. The Score for ITCI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 52.2% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

84.89

52-Week Low:

45.50

Prediction Charts

Market Cap:

8.13B

Price in USD:

76.97

Volume:

544.3K

Beta:

1.07

Technical Analysis

SMA50:

75.78

SMA100:

72.48

SMA200:

70.50

52-Wk Change:

41.59%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 76.97 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Aug-30	72.27	73.28	73.48	72.21
Sep-3	73.30	73.01	74.73	72.61
Sep-4	72.61	72.66	73.09	71.75
Sep-5	73.13	72.46	73.13	71.80
Sep-6	74.89	73.52	76.12	73.02
Sep-9	73.86	74.41	76.34	73.71
Sep-10	74.80	73.56	75.16	73.22
Sep-11	73.62	74.71	74.92	73.05
Sep-12	74.55	75.24	75.85	74.10
Sep-13	75.55	75.38	76.98	74.95
Sep-16	75.75	75.26	76.60	75.21
Sep-17	75.27	75.11	76.56	74.67
Sep-18	74.95	74.68	75.72	74.46
Sep-19	75.12	76.97	77.18	74.62

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.